Article Versions Notes

Gentile L, Russo M, Luigetti M, Bisogni G, Di Paolantonio A, Romano A, Guglielmino V, Arimatea I, Sabatelli M, Toscano A, et al. Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy. Brain Sciences. 2021; 11(4):515. https://doi.org/10.3390/brainsci11040515

Gentile, Luca, Massimo Russo, Marco Luigetti, Giulia Bisogni, Andrea Di Paolantonio, Angela Romano, Valeria Guglielmino, Ilenia Arimatea, Mario Sabatelli, Antonio Toscano, and et al. 2021. "Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy" Brain Sciences 11, no. 4: 515. https://doi.org/10.3390/brainsci11040515

Gentile, L., Russo, M., Luigetti, M., Bisogni, G., Di Paolantonio, A., Romano, A., Guglielmino, V., Arimatea, I., Sabatelli, M., Toscano, A., Vita, G., & Mazzeo, A. (2021). Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy. Brain Sciences, 11(4), 515. https://doi.org/10.3390/brainsci11040515